Interaction of heparin with fibrinogen using surface plasmon resonance technology: Investigation of heparin binding site on fibrinogen

Thrombosis Research

Volumn 81, Issue 4, 1996, Pages 503-509

  Raut, Sanjeev ^a   Gaffney, Patrick J ^a   Raut, S ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

fibrinogen; heparin; perfusion chromatography; surface plasmon resonance

Indexed keywords

FIBRINOGEN; HEPARIN;

ARTICLE; ASSAY; BLOOD CLOTTING; CHROMATOGRAPHY; CONTROLLED STUDY; PRIORITY JOURNAL;

EID: 0029936796     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00024-2     Document Type: Article

References (18)

1. GOLD, H.K., LEINBACH, R.C., GARABEDIAN, H.D., YASUDA, T., JOHNS, J.A., GROSSBARD, E.B., PALACIOS, J. and COLLEN, D. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 73: 347-352, 1986.
2. VERSTRAETE, M., ARNOLD, A.E.R., BROWER, R.W., COLLEN, D., de BONO, D.P., De ZWAAN, C., ERBEL, R., HILLIS, W.S., LENNANE, R.L., LUBSEN, J., MATHEY, D., REID, D.S., RUTSCH, W., SCHARTL, M., SCHOFER, J., SERRUYS, P.W., SIMMONS, M.L., UEBIS, R., VAHANIAN, A., VERHEUGT, F.W.A. and von ESSEN, R. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate. Am J Cardiol 60: 231-237, 1987.
3. MARDER, V.J., SOULEN, R.L., ATICHARTAKARN, V., BUDZYNSKI, A.Z., PARULEKAR, S., KIM, J.R., EDWARD, N., ZAHAVI, J. and ALGAZY, M. Quantitative venographic assessmrnt of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 89, 1018-1029, 1977.
4. VAIREL, E.G., BOUTY-BOYE, H., TOULEMONDE, F., DOUTREMEPUICH, C., MARSH, N.A., and GAFFNEY, P.J. Heparin and low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis. Thrombosis Research 30, 219-224, 1983.
5. HOTCHKISS, K.A., CHESTERMAN, C.N. and HOGG, P.J. Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation. Blood 84, 498-503, 1994.
6. MOHRI, H. and OHKUBO, T. Fibrinogen binds to heparin: The relationship of the binding of other adhesive proteins to heparin. Arch Biochem and Biophys 303, 27-31, 1993.
7. HOGG, P.J., and JACKSON, M. Fibrin monomer protects thrombin from inactivation by heparin-AT III: Implications for heparin efficacy. Proc Natl Acad Sci 86, 3619-3623, 1989.
8. JONSSON, U., FAGERSTAM, L., IVARSON, B., JOHNSSON, B., KARLSSON, R., LUNDH, K., LOFAS, S., PERSSON, B., ROOS, H., RONNBERG, I., SJOLANDER, S., STENBERG, E., STAHLBERG, R., URBANICZKY, C., OSTLIN, H. and MALMQUIST, M. Real-time biospecific interaction analysis using surface plasmon resonance and sensor chip technology. Bio Techniques 11, 620-627, 1991.
9. KARLSSON, R., MICHAELSSON, A. AND MATTSSON, L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensorbased analytical system. J. Immunol. Methods 145, 229-240, 1991.
10. GAFFNEY, P.J. and DOBOS, P. A structural aspect of human fibrinogen suggested by its plasmin degradation. FEES Lett 15, 13-16, 1971.
11. JAMIESON, G.A. and GAFFNEY, P.J. Nature of the high molecular weight fraction of fibrinolytic digests of human fibrinogen. Biochimica Et Biophysica Acta 154, 96-109, 1968.
12. NUSSENSWEIG, V., SELIGMAN, M., PELMART, J. and GRABAR, P. Les produits de degradation du fibrinogene humaine par la plasmine, I: Separation et prprietes physicochimiques. Annales de l'Institut Pasteur 100, 377-387, 1961.
13. RAUT, S., CORRAN, P.H. and GAFFNEY, P.J. Ultra-rapid preparation of milligram quantities of the purified polypeptide chains of human fibrinogen. J Chromatogr 660, 390-394, 1994.
14. RAUT, S., CORRAN, P.H. and GAFFNEY, P.J. Characterisation of the the chains of human fibrinogen isolated by perfusion chromatography using fibrin specific monoclonal antibodies. Thrombosis Research 79, 405-413, 1995.
15. O'SHANNESSY, D.J. Antibodies biotinylated by sugar moities. Methods Enzymol 184, 162-166, 1990.
16. PHARMACIA BIOSENSOR AB. Ligand immobilisation chemistry. BIA application handbook 4.1-4.33, 1994.
17. WATTON, J., LONGSTAFF, C., LANE, D.A., and BARROWCLIFFE, T.W. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III. Biochemistry 32, 7286-7292, 1993.
18. MOHRI, H., IWAMATSU, A. and OHKUBO, T. Heparin binding sites are located in a 40-kD gamma chain and a 36-kD beta chain fragment isolated from human fibrinogen. J Thrombosis and Thrombolysis 1, 49-54, 1994.